Abstract:OBJECTIVE:To investigate the expression of hypoxia inducible factor 1alpha (HIF-1alpha) protein and the activation of phosphoinositide 3-kinase/Akt (PI3K/Akt) signaling pathway in neurons under hypoxia ischemia condition, and to elucidate the role of PI3K/Akt on HIF-1alpha regulation in the developing neurons after hypoxia ischemia brain damage (HIBD). METHODS:Fifty-six SD rats aged 10 days were randomly divided into normal control group (n=12), sham operation group (n=12), experimental group (n=24), wortmannin treated group (n=4) and DMSO/PBS treated group (n=4). In the experimental group, the rats were anesthetized with ethyl ether. The right common carotid artery was exposed and ligated. Then, they were exposed to hypoxia in a normobaric chamber filled with 8% oxygen and 92% nitrogen for 2.5 hours. In the sham control group, the right common carotid artery was exposed but was not ligated or exposed hypoxia. In the normal control group, the rats received no further processing. For wortmannin treated group and DMSO/PBS treated group, the rats received intraventricular injection of wortmannin or DMSO/PBS 30 minutes before hypoxia ischemia. The brain tissues were harvested from the rats in the normal control, sham operation and experimental groups at 4, 8 and 24 hours after hypoxia ischemia, but in the wortmannin and DMSO/PBS treated groups only at 4 hours. The HIF-1alpha protein expression and Akt protein expression were detected with immunohistochemistry method. HIF-1alpha, Akt and p-Akt protein expression were measured by Western blot analysis. RESULTS:In the experimental group, the HIF-1alpha expression was significantly increased at 4 hours after operation, reached the peak level at 8 hours, and began to decrease at 24 hours. The p-Akt protein was significantly increased at 4 hours, and began to decrease at 8 hours. However, the expression levels of HIF-1alpha and p-Akt protein in the normal control group were extremely low at each time point. So, the expression levels of HIF-1alpha in the experimental group was significantly higher than that in the normal control groups (P < 0.01), the expression of p-Akt protein in the experimental group at 4 and 8 hours was significant higher than that in the normal control group (P < 0.05). The change of Akt protein in the experimental group was not time-dependent, and no significant difference was evident when compared with that of the normal control group (P > 0.05). Using wortmannin, the PI3K/Akt specific inhibitor, HIF-1alpha protein expression was significantly decreased when compared with the DMSO/PBS treated group and experimental group (P < 0.01). CONCLUSION:These results suggested that the HIBD of neonatal rats may activate PI3K/Akt signaling pathway and further induce the expression of HIF-1alpha, indicating PI3K/Akt signaling pathway and HIF-1alpha could be a potential target for treatment of neonatal HIBD.

Knockdown of IGF2BP3 Down-Regulates PDCD4 Levels to Attenuate Hypoxic-Ischemic Brain Damage

Effects of PI3K/Akt signaling pathway on learning and memory abilities in neonatal rats with hypoxic-ischemic brain damage

The expression of PI 3 K / Akt signaling pathway and PTEN in hippocampus of the brain and the correlation with cognitive impairment after neonatal hypoxic ischemic brain damage in rats

C/EBPα-mediated transcriptional activation of miR-134-5p entails KPNA3 inhibition and modulates focal hypoxic-ischemic brain damage in neonatal rats

2,3-Diphosphoglyceric Acid Alleviating Hypoxic-Ischemic Brain Damage through p38 MAPK Modulation

Deciphering the Protective Role of HIF-1α Downregulation on HIBD through the MALAT1/miR-140-5p/TGFBR1/NF-κB Signaling Pathway

Inhibition of the PI3K/Akt signaling pathway impedes the restoration of neurological function following hypoxic-ischemic brain damage in a neonatal rabbit model.

NKG2D knockdown improves hypoxic-ischemic brain damage by inhibiting neuroinflammation in neonatal mice

Effects of HMGB1/RAGE/cathespin B inhibitors on alleviating hippocampal injury by regulating microglial pyroptosis and caspase activation in neonatal hypoxic-ischemic brain damage

Transplantation of Placenta-Derived Mesenchymal Stem Cells Reduces Hypoxic-Ischemic Brain Damage in Rats by Ameliorating the Inflammatory Response

The Involvement of Programmed Cell Death 5 (pdcd5) in the Regulation of Apoptosis in Cerebral Ischemia/Reperfusion Injury

The Activation of PKM2 Induces Pyroptosis in Hippocampal Neurons via the NLRP3/Caspase‐1/GSDMD Pathway in Neonatal Rats With Hypoxic‐Ischemic Brain Injury

Didymin Alleviates Cerebral Ischemia-Reperfusion Injury by Activating the PPAR Signaling Pathway

[Phosphoinositide 3-Kinase/akt Pathway Involved in Regulation of Hypoxia Inducible Factor 1alpha in Hypoxia Ischemia Brain Damage of Neonatal Rats].

G-CSF Ameliorates Neuronal Apoptosis Via the Mtor/p70s6k Pathway after Hypoxia-Ischemia Brain Damage in Neonatal Rats

Activation of the AKT/GSK-3β/β-catenin pathway via photobiomodulation therapy promotes neural stem cell proliferation in neonatal rat models of hypoxic-ischemic brain damage

Hypoxia ischemia results in blood brain barrier damage via AKT/GSK-3β/CREB pathway in neonatal rats

KLF2 up-regulates IRF4/HDAC7 to protect neonatal rats from hypoxic-ischemic brain damage

G-CSF Ameliorates Neuronal Apoptosis Through GSK-3β Inhibition in Neonatal Hypoxia–ischemia in Rats

Role of PPAR-β/δ/miR-17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic-ischemic injury in rats

Preconditioning Suppresses Inflammation in Neonatal Hypoxic Ischemia Via Akt Activation